4.1 Review

Autophagy in Alzheimer's disease

Journal

EXPERT REVIEW OF NEUROTHERAPEUTICS
Volume 10, Issue 7, Pages 1209-1218

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/ERN.10.84

Keywords

Alzheimer's disease; autophagy; death; neurodegeneration; protection; therapeutic target

Funding

  1. Anavex
  2. Canopus BioPharma
  3. Medivation
  4. Neurotez
  5. Neuropharm
  6. Panacea Pharmaceuticals
  7. Voyager Pharmaceuticals

Ask authors/readers for more resources

Autophagy is a degradation pathway for the turnover of dysfunctional organelles or aggregated proteins in cells. Extensive literature exists supporting a causative role of mitochondrial dysfunction and amyloid-beta protein in the pathogenesis of Alzheimer's disease (AD). Furthermore, a link between mitochondrial dysfunction, amyloid-beta levels and autophagy has been reported to occur in AD. However, it is not yet clear if autophagy plays a causative role, a protective role or is a consequence of the disease process itself. Understanding the exact role of autophagy in different stages of AD progression may help to design more effective therapeutic strategies. A central issue in developing therapies for neurodegenerative diseases involves understanding why and when responses to stress or injury can help prevent neuronal degeneration and death.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available